Chromosomal translocations involving the ETS transcription factors, such as ERG and ETV1, are frequent events in human prostate cancer pathogenesis. In particular, the TMPRSS2-ERG fusion gene has recently been found to be the most frequent gene rearrangement in prostate cancers, occurring in 45-65% of North American patients. Recent reports have demonstrated a strong correlation between the presence of the TMPRSS2-ERG rearrangement and expression of the ERG protein. Other studies have shown a strong concordance of ERG positive prostatic intraepithelial neoplasm (PIN) in ERG positive carcinoma in prostatectomies (with 99.9% specificity). Therefore, as a hallmark of the TMPRSS2-ERG chromosomal translocation, ERG expression offers a rare, but definitive marker of adenocarcinoma of prostatic origin, and a unique opportunity to identify a potentially clinically significant subset of prostate cancer patients by IHC. Given the ease of performing IHC vs. FISH, ERG protein expression in formalin-fixed paraffin-embedded tissue may be an extremely useful tool for the routine identification of the ERG gene rearrangement and diagnosis of prostate adenocarcinoma.
Note: Clone 9FY was developed by the Center for Disease and Prostate Research in association with the Henry Jackson Foundation, Rockville, Maryland.
CK5 is a type II intermediate filament protein that is expressed in active basal layers of most epithelia including normal prostate and normal breast tissues. CK5 stains normal basal cell layers in normal glands, benign glands (Benign Prostatic Hyperplasia, (BPH) and prostatic intraepithelial neoplasia (PIN).
The combination of ERG and CK5 provides a unique stain that identifies the TMPRSS2-ERG chromosomal translocation in prostate cancer (DAB), but also highlights PIN in red; thus helping to visualize ERG positive PINs.
| Specifications | |
|---|---|
| Intended Use | IVD |
| Source | Mouse Monoclonal, Rabbit Monoclonal |
| Species Reactivity | Human, Others not tested |
| Clone | 9FY + EP1601Y |
| Isotype | IgG1 + N/A |
| Antigen | CK5, ERG |
| Cellular Localization | CK5 (Cytoplasmic): Red, ERG (Nuclear): Brown |
| Positive Control | ERG positive prostate cancer |
| Normal Tissue | Normal Prostate |
| Abnormal Tissue | Benign Glands, ERG positive prostate, PIN |
| Ordering Information | Catalog Number | Volume |
|---|---|---|
| Concentrate | N/A | N/A |
| Predilute | API 437DS | AA |
| intelliPATH™ | N/A | N/A |
| VP Echelon | AVI 437DSK | G |
| A / AK = 0.1 ml | B / BK = 0.5 ml | C / CK = 1.0 ml | G5 = 5.0 ml | AA = 6.0 ml | H / G25 = 25 ml | L = 100 ml |
|---|
| Data Sheets |
|---|
| Download Data Sheet |
| Download VP Echelon Data Sheet |